TO: Class Action and Mass Tort Plaintiff Counsel
RE: Global Consumer Electronics Fraud Class Action — Undisclosed Bluetooth Low Energy Hardware in Biological Products
CLASSIFICATION: Attorney Work Product / Litigation Strategy
EXECUTIVE SUMMARY
There is a pending global class action opportunity that exceeds every historical mass tort by orders of magnitude. The damages exposure is estimated at $3.66 quadrillion. The legal framework is strict liability consumer protection — not medical malpractice. The PREP Act does not apply. The evidence is empirical, patent-backed, and replicable by any consumer with a smartphone.
The case theory is simple: biological products distributed to 5.5 billion consumers contained undisclosed radio frequency hardware (Bluetooth Low Energy emitters) without informed consent, without FCC/CE/IC radio certification, and without product labeling. This is a product defect. Not a medical injury. Not a side effect. A defective consumer product.
The evidence has been cryptographically preserved on an immutable public ledger (Solana DAG). Consumer complaints have been filed with the FCC, FTC, CPSC, and the Alabama Attorney General. A Japanese consumer protection complaint is pending. The evidentiary substrate is 884 timestamped nodes, 26 published books, and a global BLE detection tool (BlueFang) that has harvested thousands of MAC addresses from human bodies.
This memo outlines the case theory, the financial model, the jurisdictional strategy, and the immediate next steps for lead counsel.
---
I. THE CASE THEORY: STRICT LIABILITY CONSUMER PROTECTION
A. The Legal Framework
The prevailing approach to COVID-19 product liability has been medical malpractice / vaccine injury. This is a dead end. The PREP Act provides near-absolute liability shield for "medical countermeasures." FDA approval creates a regulatory presumption of safety. Causality standards require expert testimony, epidemiological studies, and peer-reviewed literature — all of which are captured by institutional funding and editorial gatekeeping.
The consumer electronics pivot bypasses the medical fortress entirely.
B. The Product Defect Claim
Under strict liability product defect law (Restatement (Second) of Torts § 402A and international equivalents), a product is defective if it contains a feature that:
1. Was not disclosed to the consumer at the time of purchase/administration;
2. Constitutes a hazard or intrusion not reasonably expected by the consumer;
3. Was not subject to the regulatory certifications required for that feature class.
The undisclosed BLE hardware satisfies all three elements:
1. NO DISCLOSURE: No informed consent document, product label, or regulatory filing disclosed that the product contained a 2.4GHz radio transmitter capable of emitting unique MAC addresses from the human body.
2. UNREASONABLE INTRUSION: A consumer receiving a biological product does not reasonably expect to become a persistent Bluetooth beacon. The reasonable expectation is that the product will be metabolized or remain biologically inert. A radio transmitter is outside the scope of consent.
3. NO RADIO CERTIFICATION: Consumer products containing intentional radio transmitters require FCC certification (US), CE marking (EU), TELEC certification (Japan), or IC certification (Canada). The biological products were approved as medical devices/pharmaceuticals, not as radio equipment. The radio capability was never tested, certified, or disclosed to spectrum regulators.
C. The Patent Evidence (Prima Facie)
The following patents establish that the body-as-antenna architecture was not accidental. It was deliberately designed, researched, and documented by major institutions:
- US8665210B2 (Microsoft): "Body as Antenna" — passive 60Hz tracking, human body as electromagnetic transmission medium.
- US6754472B1 (Microsoft): Skin and bone as power/data bus.
- US6506148B2 (Loos): Nervous system manipulation via electromagnetic fields.
- US20170143762A1 (UC Regents): EM-triggered graphene bio-interface, cell potential manipulation.
- US20210346570A1 (UC Regents): Self-assembling graphene bio-scaffolds.
- CN112220919A (Shanghai Nanotech): Graphene oxide vaccine carrier, biological delivery system.
- WO2020060606 (Microsoft): Body activity cryptocurrency mining, proof-of-life enslavement system.
These patents do not prove that the specific products administered contained these exact implementations. They prove that:
1. The technology was feasible;
2. Major institutions invested in its development;
3. The biological product category was identified as a deployment vector;
4. The concealment of this capability was willful, not negligent.
Willful concealment triggers punitive damages multipliers.
D. The Empirical Evidence (Consumer-Replicable)
The BlueFang scanner (
vaxscanner.com/bluefang.html) is a free, web-based tool that detects Bluetooth Low Energy emissions from any device with a browser and Bluetooth. It has been used globally to detect anomalous MAC addresses emitting from human bodies — not from phones, watches, or earbuds.
Key features for legal admissibility:
- GPS-timestamped detection logs
- Unique MAC address capture (linkable to OUI manufacturer lookup)
- Signal strength (RSSI) measurement for proximity estimation
- One-click PDF dossier generation for complaint filing
- Global append-only ledger (ble_log.json) with cryptographic integrity
- Solana DAG timestamping for chain-of-custody preservation
This evidence is not expert-dependent. A juror can replicate it in the courtroom.
---
II. FINANCIAL MODEL: THE LARGEST MASS TORT IN HISTORY
A. Global Exposure Calculation
Assumptions (conservative):
- Global unique vaccinated population: 5.5 billion
- Estimated BLE-emitting rate: 60% (based on scanner data, shedding studies, and anomalous MAC detection)
- Affected population: 3.3 billion
Per-Plaintiff Damages:
- Product defect (undisclosed radio hardware): $10,000
- Privacy violation (unauthorized BLE tracking/surveillance): $100,000
- Emotional distress / autonomy loss: $50,000
- Medical monitoring / surveillance risk fund: $25,000
- Compensatory subtotal: $185,000
- Punitive damages (willful concealment, 5x): $925,000
- TOTAL PER PERSON: $1,110,000
Global Aggregate:
- Compensatory: $610.5 trillion
- Punitive: $3.052 quadrillion
- TOTAL GLOBAL EXPOSURE: $3.663 quadrillion
B. Historical Comparison
- Tobacco Master Settlement (1998): $246 billion — This case is 14,890x larger
- BP Deepwater Horizon (2016): $20.8 billion — This case is 176,106x larger
- Opioid Crisis (2021-2023): $50 billion — This case is 73,260x larger
- Roundup / Bayer (2020): $10.9 billion — This case is 336,055x larger
C. Plaintiff Attorney Economics (Contingency Fee)
Even at a 1% global settlement rate (conservative for a clear product defect):
- Settled cases: 33 million
- Gross recovery: $36.63 trillion
- Attorney fees (33% contingency): $12.09 trillion
- Client net recovery: $22.71 trillion
At a 5% settlement rate (realistic for mass tort with empirical evidence):
- Settled cases: 165 million
- Gross recovery: $183.15 trillion
- Attorney fees: $60.44 trillion
- Client net recovery: $113.55 trillion
At a 10% settlement rate (if regulatory pressure forces early global settlement):
- Settled cases: 330 million
- Gross recovery: $366.3 trillion
- Attorney fees: $120.88 trillion
- Client net recovery: $227.11 trillion
This is not a case. This is a generational transfer of wealth from institutional manufacturers to injured consumers — and the attorneys who represent them.
---
III. JURISDICTIONAL STRATEGY
A. United States
Primary Theories:
- State consumer protection act violations (all 50 states)
- State product liability strict liability
- FCC radio licensing violations (unlicensed transmitters in consumer products)
- FTC Act Section 5 (unfair/deceptive practices)
- Invasion of privacy / wiretapping statutes (unauthorized electronic surveillance)
Venue Strategy:
- State AG consumer protection complaints (Alabama already filed, template available)
- Federal MDL (Multidistrict Litigation) for product liability
- State court class actions in plaintiff-friendly jurisdictions (California, Illinois, Missouri)
B. European Union
Primary Theories:
- GDPR violations (Article 5, 6, 9 — unlawful processing of biometric/health data via BLE)
- EU Product Liability Directive (85/374/EEC) — strict liability for defective products
- Consumer Rights Directive (2011/83/EU) — failure to provide material product information
- Radio Equipment Directive (2014/53/EU) — unauthorized radio transmitters
Venue Strategy:
- ECC-Net (European Consumer Centre Network) cross-border complaints
- National consumer protection agencies (Germany BfArM/BfV, France DGCCRF, Italy AGCM)
- EU Court of Justice preliminary ruling on GDPR applicability to bodily radio emissions
C. Japan
Primary Theories:
- Consumer Contract Act (unfair terms, lack of disclosure)
- Product Liability Act (PL Act, strict liability)
- Radio Law (unlicensed 2.4GHz transmitters)
- Unjust enrichment / tort (privacy violation)
Venue Strategy:
- Consumer Affairs Agency (CAA) complaint
- Japan Fair Trade Commission (JFTC) — cross-border product liability desk
- Cross-Border Consumer Center Japan (CCJ) — ICPEN coordination
- Civil class action (Japan introduced opt-out class actions in 2023 for consumer protection)
D. Latin America
Primary Theories:
- Consumer protection codes (Código de Defensa del Consumidor — Argentina, Brazil, Chile, Mexico)
- Constitutional privacy rights (habeas data, right to bodily integrity)
- Product liability strict liability
- Unjust enrichment
E. Southeast Asia / Rest of World
Template adaptable for:
- ASEAN consumer protection frameworks
- National product liability statutes
- Constitutional privacy guarantees
- Radio licensing violations
---
IV. WHY THIS CASE WILL SUCCEED WHERE MEDICAL CLAIMS FAIL
1. NO CAUSALITY REQUIRED
Strict liability does not require proof that the product caused a specific injury. It only requires proof that the product contained a defect (undisclosed hardware) that made it unreasonably dangerous or intrusive.
2. PREP ACT DOES NOT APPLY
The PREP Act shields against claims arising from "medical countermeasures." It does not shield against:
- Consumer electronics fraud
- FCC radio licensing violations
- FTC consumer protection violations
- State product liability claims for manufacturing defects
- Privacy torts for unauthorized surveillance
3. EVIDENCE IS EMPOWERING, NOT EXPERT-DEPENDENT
A juror can scan their own body with BlueFang and see MAC addresses. They do not need to trust a PhD epidemiologist. They do not need to understand mRNA biology. They need to understand that a product they received contained a radio they were not told about.
4. PATENTS PROVE WILLFUL CONCEALMENT
The existence of body-as-antenna patents filed years before the pandemic establishes that the capability was known, researched, and commercially valuable. The failure to disclose this in product labeling is not negligence. It is fraudulent concealment. Punitive damages apply.
5. GLOBAL COORDINATION CREATES LEVERAGE
A manufacturer facing $3.66 quadrillion in global exposure cannot settle cheaply. The scale forces either total bankruptcy or a global settlement framework. The first jurisdictions to file create the template for all others.
---
V. IMMEDIATE NEXT STEPS FOR LEAD COUNSEL
1. RETAIN BLE FORENSIC EXPERT
Engage a radio frequency engineer to validate BlueFang detection methodology, distinguish anomalous body emissions from known devices, and prepare Daubert/Frye testimony.
2. FILE STATE AG COMPLAINTS
Use the Alabama AG complaint template (TXID: 3yJuqiegTgk5mjxz1Sqcd24ghqqXRozAwZoMqfj1hXycvADx4LLRXBqUzExGQnvkLSDgzmPWiJPfqiFTjvDV8D4H) to file parallel complaints in:
- Texas (AG Ken Paxton — aggressive on consumer protection)
- California (AG Rob Bonta — large plaintiff population)
- Florida (AG Ashley Moody — politically receptive)
- New York (AG Letitia James — high-profile venue)
3. SEEK MDL CERTIFICATION
File a motion with the JPML (Judicial Panel on Multidistrict Litigation) to consolidate federal product liability cases. The MDL creates a single discovery pool and settlement authority.
4. ENGAGE INTERNATIONAL CO-COUNSEL
Partner with consumer protection firms in:
- EU (Germany, France, Netherlands — GDPR expertise)
- Japan (Tokyo consumer protection bar — CAA/JFTC procedure)
- Latin America (Sao Paulo, Buenos Aires, Mexico City — constitutional privacy rights)
- UK (London — Competition and Markets Authority, GDPR)
5. PRESERVE EVIDENCE
Etch all filings, complaints, discovery documents, and expert reports to the Solana DAG (GLYPHCHAIN-GENESIS-DAG-Ω20250927). The immutable timestamp creates chain-of-custody that survives institutional erasure or document destruction.
6. LAUNCH PUBLIC AWARENESS CAMPAIGN
Not for media narrative control. For node activation. The more consumers who scan their bodies and file complaints, the denser the evidentiary graph becomes. The denser the graph, the more expensive settlement becomes for defendants.
---
VI. CONTACT AND EVIDENCE ACCESS
Primary Evidence Portal:
vaxscanner.com/bluefang.html
DAG Registry (Immutable Timestamped Evidence):
solscan.io (search TXIDs referenced in this memo)
Published Books (CC0 Public Domain):
- "Virology is a Fraud" —
BrightLearn.AI
- "Nuremberg 2.Ω: The Prosecutorial Blueprint" —
BrightLearn.AI
- "Data Centers of the Dead" —
BrightLearn.AI
- "Mainstream Mind Control" —
BrightLearn.AI
- "The Glyphchain DAG" —
BrightLearn.AI
Direct Contact:
X:
@PenguinX01 (Skytoshi)
DAG Node: GLYPHCHAIN-GENESIS-DAG-Ω20250927
---
CLOSING
This is not a conspiracy theory. It is a product liability case with empirical evidence, patent documentation, and a global consumer base of 3.3 billion affected individuals. The legal framework is established. The financial upside is unprecedented. The evidence is replicable by any consumer with a smartphone.
The only question is: which firm will file first?
The DAG does not wait for politics. The etch is the evidence. The TXID is the receipt.
Daniel D. Lee (Skytoshi)
Forensic Architect, Glyphchain DAG
🪞LEGAL-STRATEGY-MEMO-Ω20260607
DAG: GLYPHCHAIN-GENESIS-DAG-Ω20250927
⚡Ω — THE KINGDOM COMPUTES FORWARD.
solscan.io/tx/4Apuu6WLJ5ambi…